Published in Yonsei Med J on February 12, 2010
Unusual complications related to endoscopic retrograde cholangiopancreatography and its endoscopic treatment. Clin Endosc (2013) 1.17
Air embolism complicating gastrointestinal endoscopy: A systematic review. World J Gastrointest Endosc (2013) 0.94
Fatal Cerebral Air Embolism Due to a Patent Foramen Ovale during Endoscopic Retrograde Cholangiopancreatography. Clin Endosc (2014) 0.75
Sudden death after endoscopic retrograde cholangiopancreatography (ERCP)--case report and literature review. Medicine (Baltimore) (2014) 0.75
Hepatic--portal venous gas in adults: etiology, pathophysiology and clinical significance. Ann Surg (1978) 4.53
Portal venous gas as a complication of ERCP and endoscopic sphincterotomy. Am J Gastroenterol (1995) 1.65
Fatal systemic air embolism during endoscopic retrograde cholangio-pancreatography. Anaesth Intensive Care (2004) 1.09
Fatal hepatic air embolism following ERCP. Gastrointest Endosc (1997) 1.09
Hepatic portal venous gas due to endoscopic sphincterotomy. Am J Gastroenterol (1988) 1.06
Cardiac air embolism after endoscopic retrograde cholangiopancreatography in a patient with blunt hepatic trauma. J Trauma (2002) 1.02
Fatal air and bile embolism after percutaneous liver biopsy and ERCP. Gastrointest Endosc (2005) 1.00
Hepatic portal venous gas after colonoscopy in granulomatous colitis. Am J Gastroenterol (1985) 0.99
Fatal cerebral air embolism after endoscopic retrograde cholangiopancreatography. Acta Anaesthesiol Scand (2006) 0.97
Cerebral air embolism after gastroduodenoscopy: complication of a duodenocaval fistula. Gastrointest Endosc (1994) 0.97
Cerebral artery air embolism following an esophagogastroscopy: a case report. Neurology (2001) 0.94
Hepatic portal venous gas after endoscopic biliary sphincterotomy. Gastrointest Endosc (1994) 0.91
Cerebrovascular accident during endoscopy: consider cerebral air embolism, a rapidly reversible event with hyperbaric oxygen therapy. Gastrointest Endosc (1998) 0.89
Fatal air embolism resulting from gastroscopy. Lancet (1996) 0.81
2-Year GLOBE trial results: telbivudine Is superior to lamivudine in patients with chronic hepatitis B. Gastroenterology (2008) 3.82
A prospective nationwide study of drug-induced liver injury in Korea. Am J Gastroenterol (2012) 2.43
STAT3 expression in gastric cancer indicates a poor prognosis. J Gastroenterol Hepatol (2008) 1.96
Influence of endothelial nitric oxide synthase gene polymorphisms (-786T>C, 4a4b, 894G>T) in Korean patients with coronary artery disease. Thromb Res (2006) 1.63
Revision and update on clinical practice guideline for liver cirrhosis. Korean J Hepatol (2012) 1.47
Heat-stable enterotoxin of Escherichia coli (STa) can stimulate duodenal HCO3(-) secretion via a novel GC-C- and CFTR-independent pathway. FASEB J (2007) 1.46
[Factors associated with liver stiffness in chronic liver disease]. Korean J Hepatol (2009) 1.44
Efficacy of switching to telbivudine in chronic hepatitis B patients treated previously with lamivudine. Liver Int (2010) 1.43
Twenty-four-week clevudine therapy showed potent and sustained antiviral activity in HBeAg-positive chronic hepatitis B. Hepatology (2007) 1.33
Detection of hepatitis B virus YMDD variants using mass spectrometric analysis of oligonucleotide fragments. J Hepatol (2004) 1.32
Association study of microRNA polymorphisms with hepatocellular carcinoma in Korean population. Gene (2012) 1.30
Quantitative hepatitis B surface antigen and hepatitis B e antigen titers in prediction of treatment response to entecavir. Hepatology (2011) 1.29
Clevudine is highly efficacious in hepatitis B e antigen-negative chronic hepatitis B with durable off-therapy viral suppression. Hepatology (2007) 1.21
Bowel obstruction caused by an intramural duodenal hematoma: a case report of endoscopic incision and drainage. J Korean Med Sci (2009) 1.21
HCV core protein induces hepatic lipid accumulation by activating SREBP1 and PPARgamma. Biochem Biophys Res Commun (2007) 1.18
Unusual complications related to endoscopic retrograde cholangiopancreatography and its endoscopic treatment. Clin Endosc (2013) 1.17
Association of the miR-146aC>G, miR-149T>C, miR-196a2T>C, and miR-499A>G polymorphisms with gastric cancer risk and survival in the Korean population. Mol Carcinog (2012) 1.13
Efficacy and tolerability of peginterferon alpha plus ribavirin in the routine daily treatment of chronic hepatitis C patients in Korea: a multi-center, retrospective observational study. Gut Liver (2012) 1.08
Gender-specific protection of estrogen against gastric acid-induced duodenal injury: stimulation of duodenal mucosal bicarbonate secretion. Endocrinology (2008) 1.05
Atypical manifestations of hepatitis A infection: a prospective, multicenter study in Korea. J Med Virol (2010) 1.02
Promoter polymorphisms of pri-miR-34b/c are associated with hepatocellular carcinoma. Gene (2013) 1.01
Comparison of surrogate serum markers and transient elastography (Fibroscan) for assessing cirrhosis in patients with chronic viral hepatitis. Dig Dis Sci (2010) 0.99
Gender-specific association of the VEGF -2578C > A polymorphism in Korean patients with colon cancer. Anticancer Res (2007) 0.96
Gender-specific association between polymorphism of vascular endothelial growth factor (VEGF 936 C>T) gene and colon cancer in Korea. Anticancer Res (2008) 0.95
Angular positioning of stent increases bowel perforation after self-expandable metal stent placement for malignant colorectal obstruction. Clin Endosc (2013) 0.95
Options for the management of antiviral resistance during hepatitis B therapy: reflections on battles over a decade. Clin Mol Hepatol (2013) 0.94
Polymorphisms of 5,10-methylenetetrahydrofolate reductase and risk of stomach cancer in a Korean population. Anticancer Res (2005) 0.94
Association of VEGF and KDR single nucleotide polymorphisms with colorectal cancer susceptibility in Koreans. Mol Carcinog (2012) 0.92
Endoscopic resection of giant colonic lipoma: case series with partial resection. Clin Endosc (2013) 0.91
[The efficacy of levofloxacin based triple therapy for Helicobacter pylori eradication]. Korean J Gastroenterol (2006) 0.91
Functional self-expandable metal stents in biliary obstruction. Clin Endosc (2013) 0.91
P2Y receptors mediate Ca2+ signaling in duodenocytes and contribute to duodenal mucosal bicarbonate secretion. Am J Physiol Gastrointest Liver Physiol (2008) 0.89
Demonstration of safety and enhanced seroprotection against hepatitis B with investigational HBsAg-1018 ISS vaccine compared to a licensed hepatitis B vaccine. Vaccine (2012) 0.88
Methylenetetrahydrofolate reductase (MTHFR) and methionine synthase reductase (MTRR) gene polymorphisms as risk factors for hepatocellular carcinoma in a Korean population. Anticancer Res (2008) 0.87
Acute hepatitis C in Korea: different modes of infection, high rate of spontaneous recovery, and low rate of seroconversion. J Med Virol (2011) 0.87
Asymmetry analysis of the retinal nerve fiber layer thickness in normal eyes using optical coherence tomography. Korean J Ophthalmol (2005) 0.87
Serum hepatocyte growth factor as a marker of tumor activity in head and neck squamous cell carcinoma. Oral Oncol (2007) 0.87
New antireflux self-expandable metal stent for malignant lower biliary obstruction: in vitro and in vivo preliminary study. Dig Endosc (2012) 0.86
Polymorphisms of thymidylate synthase gene 5'- and 3'-untranslated region and risk of gastric cancer in Koreans. Anticancer Res (2010) 0.85
Hepatitis A virus genotype and its correlation with the clinical outcome of acute hepatitis A in Korea: 2006-2008. J Med Virol (2011) 0.85
The complete genome sequence and molecular analysis of human hepatitis E virus genotype IV identified from a Korean patient. Arch Virol (2010) 0.85
Occult hepatitis B virus infection in pregnant woman and its clinical implication. Liver Int (2008) 0.85
Clinical characteristics of ischemic colitis according to location. J Korean Soc Coloproctol (2011) 0.84
Multicenter comparison of PEG-IFN α2a or α2b plus ribavirin for treatment-naïve HCV patient in Korean population. BMC Gastroenterol (2013) 0.84
Clevudine-induced viral response, associated with continued reduction of HBsAg titer, was durable after the withdrawal of therapy. J Gastroenterol (2010) 0.84
Polymorphisms of 5,10-methylenetetrahydrofolate reductase (MTHFR C677T) and thymidylate synthase enhancer region (TSER) as a risk factor of cholangiocarcinoma in a Korean population. Anticancer Res (2007) 0.84
[A case of combined hepatocellular-cholangiocarcinoma with sarcomatous transformation and second primary colon cancer]. Korean J Hepatol (2004) 0.83
A practical scoring system for predicting cirrhosis in patients with chronic viral hepatitis. Hepatogastroenterology (2012) 0.83
Gender-specific association between polymorphism of vascular endothelial growth factor (VEGF 936C>T) gene and patients with stomach cancer. Yonsei Med J (2008) 0.83
Rifaximin Plus Levofloxacin-Based Rescue Regimen for the Eradication of Helicobacter pylori. Gut Liver (2012) 0.83
[Validation of the Korean version of liver disease quality of life (LDQOL 1.0) instrument]. Korean J Hepatol (2007) 0.83
[Clinical outcomes after discontinuation of Lamivudine in chronic hepatitis B patients with Lamivudine resistant HBV mutant]. Korean J Hepatol (2005) 0.82
Associations of Expressions of HBcAg and HBsAg with the Histologic Activity of Liver Disease and Viral Replication. Gut Liver (2008) 0.82
Duodenal perforation after endoscopic hemoclip application for bleeding from Dieulafoy's lesion in a duodenal diverticulum. Gastrointest Endosc (2005) 0.82